Bettzy Stephen

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

PD-1 ⁺ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Secure, privacy-preserving and federated machine learning in medical imaging

Head and neck squamous cell carcinoma

The evidence framework for precision cancer medicine

Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management

Nomograms in oncology: more than meets the eye

Current and future perspectives of liquid biopsies in genomics-driven oncology

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma

Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology Trials

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

Radiomics to predict immunotherapy-induced pneumonitis: proof of concept

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience